Medical Care
Global Induced Pluripotent Stem Cells Service Market Research Report 2024
- Mar 11, 25
- ID: 6415
- Pages: 90
- Figures: 90
- Views: 2
The global market for Induced Pluripotent Stem Cells Service was valued at US$ 2683 million in the year 2023 and is projected to reach a revised size of US$ 5339 million by 2030, growing at a CAGR of 10.4% during the forecast period.
Induced pluripotent stem cell (iPSC) services refer to a series of professional technologies and processes designed to reprogram pluripotent stem cells from adult cells (such as skin or blood cells). These cells can self-renew and differentiate into a variety of cell types, and have a wide range of application potential, including regenerative medicine, drug screening, and disease model construction. iPSC manufacturing services are the core of iPSC services, including the selection of cell sources and the implementation of cell reprogramming. Through precise induction technology, researchers can convert mature somatic cells into iPSCs. iPSC reprogramming services focus on using various methods (such as viral vectors, transfection, or small molecule compounds) to achieve cell reprogramming. These methods can effectively improve the efficiency of reprogramming and the safety of cells. Once iPSCs are generated, iPSC culture services become key. This service ensures that iPSCs grow under optimal conditions, maintain their pluripotency, and avoid differentiation. Next, iPSC differentiation services can be used to induce iPSCs to differentiate into specific cell types, such as neurons, cardiomyocytes, etc., to meet research and treatment needs. In addition, iPSC gene editing services enable researchers to make precise gene modifications in iPSCs, facilitating the study of gene function, disease mechanisms, and the development of personalized treatment plans. In summary, induced pluripotent stem cell services cover multiple aspects such as iPSC manufacturing, reprogramming, culture, differentiation, and gene editing, providing strong support for regenerative medicine and biomedical research.
North American market for Induced Pluripotent Stem Cells Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Induced Pluripotent Stem Cells Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Induced Pluripotent Stem Cells Service in Pharmaceutical Company is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Induced Pluripotent Stem Cells Service include Lonza, Thermo Fisher Scientific Inc., FUJIFILM Cellular Dynamics, Inc. (FCDI), Charles River Laboratories, Novo Holdings (Catalent, Inc), Creative Bioarray, Creative Biolabs, iXCells Biotechnologies, Creative Biogene, Axol Bioscience Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Induced Pluripotent Stem Cells Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Induced Pluripotent Stem Cells Service.
The Induced Pluripotent Stem Cells Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Induced Pluripotent Stem Cells Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Induced Pluripotent Stem Cells Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Thermo Fisher Scientific Inc.
FUJIFILM Cellular Dynamics, Inc. (FCDI)
Charles River Laboratories
Novo Holdings (Catalent, Inc)
Creative Bioarray
Creative Biolabs
iXCells Biotechnologies
Creative Biogene
Axol Bioscience Ltd.
Elixirgen Scientific, Inc.
Cyagen
ALSTEM
uBriGene Biosciences International Co.
NEXEL Co., Ltd.
Segment by Type
iPSC Manufacturing Service
iPSC Reprogramming Service
iPSC Culture Service
iPSC Differentiation Service
iPSC Gene Editing Service
Other
Segment by Application
Pharmaceutical Company
Laboratory
Scientific Research Institution
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Induced Pluripotent Stem Cells Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Induced pluripotent stem cell (iPSC) services refer to a series of professional technologies and processes designed to reprogram pluripotent stem cells from adult cells (such as skin or blood cells). These cells can self-renew and differentiate into a variety of cell types, and have a wide range of application potential, including regenerative medicine, drug screening, and disease model construction. iPSC manufacturing services are the core of iPSC services, including the selection of cell sources and the implementation of cell reprogramming. Through precise induction technology, researchers can convert mature somatic cells into iPSCs. iPSC reprogramming services focus on using various methods (such as viral vectors, transfection, or small molecule compounds) to achieve cell reprogramming. These methods can effectively improve the efficiency of reprogramming and the safety of cells. Once iPSCs are generated, iPSC culture services become key. This service ensures that iPSCs grow under optimal conditions, maintain their pluripotency, and avoid differentiation. Next, iPSC differentiation services can be used to induce iPSCs to differentiate into specific cell types, such as neurons, cardiomyocytes, etc., to meet research and treatment needs. In addition, iPSC gene editing services enable researchers to make precise gene modifications in iPSCs, facilitating the study of gene function, disease mechanisms, and the development of personalized treatment plans. In summary, induced pluripotent stem cell services cover multiple aspects such as iPSC manufacturing, reprogramming, culture, differentiation, and gene editing, providing strong support for regenerative medicine and biomedical research.
North American market for Induced Pluripotent Stem Cells Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Induced Pluripotent Stem Cells Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Induced Pluripotent Stem Cells Service in Pharmaceutical Company is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Induced Pluripotent Stem Cells Service include Lonza, Thermo Fisher Scientific Inc., FUJIFILM Cellular Dynamics, Inc. (FCDI), Charles River Laboratories, Novo Holdings (Catalent, Inc), Creative Bioarray, Creative Biolabs, iXCells Biotechnologies, Creative Biogene, Axol Bioscience Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Induced Pluripotent Stem Cells Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Induced Pluripotent Stem Cells Service.
The Induced Pluripotent Stem Cells Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Induced Pluripotent Stem Cells Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Induced Pluripotent Stem Cells Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Thermo Fisher Scientific Inc.
FUJIFILM Cellular Dynamics, Inc. (FCDI)
Charles River Laboratories
Novo Holdings (Catalent, Inc)
Creative Bioarray
Creative Biolabs
iXCells Biotechnologies
Creative Biogene
Axol Bioscience Ltd.
Elixirgen Scientific, Inc.
Cyagen
ALSTEM
uBriGene Biosciences International Co.
NEXEL Co., Ltd.
Segment by Type
iPSC Manufacturing Service
iPSC Reprogramming Service
iPSC Culture Service
iPSC Differentiation Service
iPSC Gene Editing Service
Other
Segment by Application
Pharmaceutical Company
Laboratory
Scientific Research Institution
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Induced Pluripotent Stem Cells Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Induced Pluripotent Stem Cells Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 iPSC Manufacturing Service
1.2.3 iPSC Reprogramming Service
1.2.4 iPSC Culture Service
1.2.5 iPSC Differentiation Service
1.2.6 iPSC Gene Editing Service
1.2.7 Other
1.3 Market by Application
1.3.1 Global Induced Pluripotent Stem Cells Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Company
1.3.3 Laboratory
1.3.4 Scientific Research Institution
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Induced Pluripotent Stem Cells Service Market Perspective (2019-2030)
2.2 Global Induced Pluripotent Stem Cells Service Growth Trends by Region
2.2.1 Global Induced Pluripotent Stem Cells Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Induced Pluripotent Stem Cells Service Historic Market Size by Region (2019-2024)
2.2.3 Induced Pluripotent Stem Cells Service Forecasted Market Size by Region (2025-2030)
2.3 Induced Pluripotent Stem Cells Service Market Dynamics
2.3.1 Induced Pluripotent Stem Cells Service Industry Trends
2.3.2 Induced Pluripotent Stem Cells Service Market Drivers
2.3.3 Induced Pluripotent Stem Cells Service Market Challenges
2.3.4 Induced Pluripotent Stem Cells Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Induced Pluripotent Stem Cells Service Players by Revenue
3.1.1 Global Top Induced Pluripotent Stem Cells Service Players by Revenue (2019-2024)
3.1.2 Global Induced Pluripotent Stem Cells Service Revenue Market Share by Players (2019-2024)
3.2 Global Induced Pluripotent Stem Cells Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Induced Pluripotent Stem Cells Service Revenue
3.4 Global Induced Pluripotent Stem Cells Service Market Concentration Ratio
3.4.1 Global Induced Pluripotent Stem Cells Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Induced Pluripotent Stem Cells Service Revenue in 2023
3.5 Global Key Players of Induced Pluripotent Stem Cells Service Head office and Area Served
3.6 Global Key Players of Induced Pluripotent Stem Cells Service, Product and Application
3.7 Global Key Players of Induced Pluripotent Stem Cells Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Induced Pluripotent Stem Cells Service Breakdown Data by Type
4.1 Global Induced Pluripotent Stem Cells Service Historic Market Size by Type (2019-2024)
4.2 Global Induced Pluripotent Stem Cells Service Forecasted Market Size by Type (2025-2030)
5 Induced Pluripotent Stem Cells Service Breakdown Data by Application
5.1 Global Induced Pluripotent Stem Cells Service Historic Market Size by Application (2019-2024)
5.2 Global Induced Pluripotent Stem Cells Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Induced Pluripotent Stem Cells Service Market Size (2019-2030)
6.2 North America Induced Pluripotent Stem Cells Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Induced Pluripotent Stem Cells Service Market Size by Country (2019-2024)
6.4 North America Induced Pluripotent Stem Cells Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Induced Pluripotent Stem Cells Service Market Size (2019-2030)
7.2 Europe Induced Pluripotent Stem Cells Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Induced Pluripotent Stem Cells Service Market Size by Country (2019-2024)
7.4 Europe Induced Pluripotent Stem Cells Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Induced Pluripotent Stem Cells Service Market Size (2019-2030)
8.2 Asia-Pacific Induced Pluripotent Stem Cells Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Induced Pluripotent Stem Cells Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Induced Pluripotent Stem Cells Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Induced Pluripotent Stem Cells Service Market Size (2019-2030)
9.2 Latin America Induced Pluripotent Stem Cells Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Induced Pluripotent Stem Cells Service Market Size by Country (2019-2024)
9.4 Latin America Induced Pluripotent Stem Cells Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Induced Pluripotent Stem Cells Service Market Size (2019-2030)
10.2 Middle East & Africa Induced Pluripotent Stem Cells Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Induced Pluripotent Stem Cells Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Induced Pluripotent Stem Cells Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Induced Pluripotent Stem Cells Service Introduction
11.1.4 Lonza Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.1.5 Lonza Recent Development
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Details
11.2.2 Thermo Fisher Scientific Inc. Business Overview
11.2.3 Thermo Fisher Scientific Inc. Induced Pluripotent Stem Cells Service Introduction
11.2.4 Thermo Fisher Scientific Inc. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.2.5 Thermo Fisher Scientific Inc. Recent Development
11.3 FUJIFILM Cellular Dynamics, Inc. (FCDI)
11.3.1 FUJIFILM Cellular Dynamics, Inc. (FCDI) Company Details
11.3.2 FUJIFILM Cellular Dynamics, Inc. (FCDI) Business Overview
11.3.3 FUJIFILM Cellular Dynamics, Inc. (FCDI) Induced Pluripotent Stem Cells Service Introduction
11.3.4 FUJIFILM Cellular Dynamics, Inc. (FCDI) Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.3.5 FUJIFILM Cellular Dynamics, Inc. (FCDI) Recent Development
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Details
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Induced Pluripotent Stem Cells Service Introduction
11.4.4 Charles River Laboratories Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.4.5 Charles River Laboratories Recent Development
11.5 Novo Holdings (Catalent, Inc)
11.5.1 Novo Holdings (Catalent, Inc) Company Details
11.5.2 Novo Holdings (Catalent, Inc) Business Overview
11.5.3 Novo Holdings (Catalent, Inc) Induced Pluripotent Stem Cells Service Introduction
11.5.4 Novo Holdings (Catalent, Inc) Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.5.5 Novo Holdings (Catalent, Inc) Recent Development
11.6 Creative Bioarray
11.6.1 Creative Bioarray Company Details
11.6.2 Creative Bioarray Business Overview
11.6.3 Creative Bioarray Induced Pluripotent Stem Cells Service Introduction
11.6.4 Creative Bioarray Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.6.5 Creative Bioarray Recent Development
11.7 Creative Biolabs
11.7.1 Creative Biolabs Company Details
11.7.2 Creative Biolabs Business Overview
11.7.3 Creative Biolabs Induced Pluripotent Stem Cells Service Introduction
11.7.4 Creative Biolabs Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.7.5 Creative Biolabs Recent Development
11.8 iXCells Biotechnologies
11.8.1 iXCells Biotechnologies Company Details
11.8.2 iXCells Biotechnologies Business Overview
11.8.3 iXCells Biotechnologies Induced Pluripotent Stem Cells Service Introduction
11.8.4 iXCells Biotechnologies Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.8.5 iXCells Biotechnologies Recent Development
11.9 Creative Biogene
11.9.1 Creative Biogene Company Details
11.9.2 Creative Biogene Business Overview
11.9.3 Creative Biogene Induced Pluripotent Stem Cells Service Introduction
11.9.4 Creative Biogene Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.9.5 Creative Biogene Recent Development
11.10 Axol Bioscience Ltd.
11.10.1 Axol Bioscience Ltd. Company Details
11.10.2 Axol Bioscience Ltd. Business Overview
11.10.3 Axol Bioscience Ltd. Induced Pluripotent Stem Cells Service Introduction
11.10.4 Axol Bioscience Ltd. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.10.5 Axol Bioscience Ltd. Recent Development
11.11 Elixirgen Scientific, Inc.
11.11.1 Elixirgen Scientific, Inc. Company Details
11.11.2 Elixirgen Scientific, Inc. Business Overview
11.11.3 Elixirgen Scientific, Inc. Induced Pluripotent Stem Cells Service Introduction
11.11.4 Elixirgen Scientific, Inc. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.11.5 Elixirgen Scientific, Inc. Recent Development
11.12 Cyagen
11.12.1 Cyagen Company Details
11.12.2 Cyagen Business Overview
11.12.3 Cyagen Induced Pluripotent Stem Cells Service Introduction
11.12.4 Cyagen Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.12.5 Cyagen Recent Development
11.13 ALSTEM
11.13.1 ALSTEM Company Details
11.13.2 ALSTEM Business Overview
11.13.3 ALSTEM Induced Pluripotent Stem Cells Service Introduction
11.13.4 ALSTEM Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.13.5 ALSTEM Recent Development
11.14 uBriGene Biosciences International Co.
11.14.1 uBriGene Biosciences International Co. Company Details
11.14.2 uBriGene Biosciences International Co. Business Overview
11.14.3 uBriGene Biosciences International Co. Induced Pluripotent Stem Cells Service Introduction
11.14.4 uBriGene Biosciences International Co. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.14.5 uBriGene Biosciences International Co. Recent Development
11.15 NEXEL Co., Ltd.
11.15.1 NEXEL Co., Ltd. Company Details
11.15.2 NEXEL Co., Ltd. Business Overview
11.15.3 NEXEL Co., Ltd. Induced Pluripotent Stem Cells Service Introduction
11.15.4 NEXEL Co., Ltd. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.15.5 NEXEL Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Induced Pluripotent Stem Cells Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 iPSC Manufacturing Service
1.2.3 iPSC Reprogramming Service
1.2.4 iPSC Culture Service
1.2.5 iPSC Differentiation Service
1.2.6 iPSC Gene Editing Service
1.2.7 Other
1.3 Market by Application
1.3.1 Global Induced Pluripotent Stem Cells Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Company
1.3.3 Laboratory
1.3.4 Scientific Research Institution
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Induced Pluripotent Stem Cells Service Market Perspective (2019-2030)
2.2 Global Induced Pluripotent Stem Cells Service Growth Trends by Region
2.2.1 Global Induced Pluripotent Stem Cells Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Induced Pluripotent Stem Cells Service Historic Market Size by Region (2019-2024)
2.2.3 Induced Pluripotent Stem Cells Service Forecasted Market Size by Region (2025-2030)
2.3 Induced Pluripotent Stem Cells Service Market Dynamics
2.3.1 Induced Pluripotent Stem Cells Service Industry Trends
2.3.2 Induced Pluripotent Stem Cells Service Market Drivers
2.3.3 Induced Pluripotent Stem Cells Service Market Challenges
2.3.4 Induced Pluripotent Stem Cells Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Induced Pluripotent Stem Cells Service Players by Revenue
3.1.1 Global Top Induced Pluripotent Stem Cells Service Players by Revenue (2019-2024)
3.1.2 Global Induced Pluripotent Stem Cells Service Revenue Market Share by Players (2019-2024)
3.2 Global Induced Pluripotent Stem Cells Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Induced Pluripotent Stem Cells Service Revenue
3.4 Global Induced Pluripotent Stem Cells Service Market Concentration Ratio
3.4.1 Global Induced Pluripotent Stem Cells Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Induced Pluripotent Stem Cells Service Revenue in 2023
3.5 Global Key Players of Induced Pluripotent Stem Cells Service Head office and Area Served
3.6 Global Key Players of Induced Pluripotent Stem Cells Service, Product and Application
3.7 Global Key Players of Induced Pluripotent Stem Cells Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Induced Pluripotent Stem Cells Service Breakdown Data by Type
4.1 Global Induced Pluripotent Stem Cells Service Historic Market Size by Type (2019-2024)
4.2 Global Induced Pluripotent Stem Cells Service Forecasted Market Size by Type (2025-2030)
5 Induced Pluripotent Stem Cells Service Breakdown Data by Application
5.1 Global Induced Pluripotent Stem Cells Service Historic Market Size by Application (2019-2024)
5.2 Global Induced Pluripotent Stem Cells Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Induced Pluripotent Stem Cells Service Market Size (2019-2030)
6.2 North America Induced Pluripotent Stem Cells Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Induced Pluripotent Stem Cells Service Market Size by Country (2019-2024)
6.4 North America Induced Pluripotent Stem Cells Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Induced Pluripotent Stem Cells Service Market Size (2019-2030)
7.2 Europe Induced Pluripotent Stem Cells Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Induced Pluripotent Stem Cells Service Market Size by Country (2019-2024)
7.4 Europe Induced Pluripotent Stem Cells Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Induced Pluripotent Stem Cells Service Market Size (2019-2030)
8.2 Asia-Pacific Induced Pluripotent Stem Cells Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Induced Pluripotent Stem Cells Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Induced Pluripotent Stem Cells Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Induced Pluripotent Stem Cells Service Market Size (2019-2030)
9.2 Latin America Induced Pluripotent Stem Cells Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Induced Pluripotent Stem Cells Service Market Size by Country (2019-2024)
9.4 Latin America Induced Pluripotent Stem Cells Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Induced Pluripotent Stem Cells Service Market Size (2019-2030)
10.2 Middle East & Africa Induced Pluripotent Stem Cells Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Induced Pluripotent Stem Cells Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Induced Pluripotent Stem Cells Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Induced Pluripotent Stem Cells Service Introduction
11.1.4 Lonza Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.1.5 Lonza Recent Development
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Details
11.2.2 Thermo Fisher Scientific Inc. Business Overview
11.2.3 Thermo Fisher Scientific Inc. Induced Pluripotent Stem Cells Service Introduction
11.2.4 Thermo Fisher Scientific Inc. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.2.5 Thermo Fisher Scientific Inc. Recent Development
11.3 FUJIFILM Cellular Dynamics, Inc. (FCDI)
11.3.1 FUJIFILM Cellular Dynamics, Inc. (FCDI) Company Details
11.3.2 FUJIFILM Cellular Dynamics, Inc. (FCDI) Business Overview
11.3.3 FUJIFILM Cellular Dynamics, Inc. (FCDI) Induced Pluripotent Stem Cells Service Introduction
11.3.4 FUJIFILM Cellular Dynamics, Inc. (FCDI) Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.3.5 FUJIFILM Cellular Dynamics, Inc. (FCDI) Recent Development
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Details
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Induced Pluripotent Stem Cells Service Introduction
11.4.4 Charles River Laboratories Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.4.5 Charles River Laboratories Recent Development
11.5 Novo Holdings (Catalent, Inc)
11.5.1 Novo Holdings (Catalent, Inc) Company Details
11.5.2 Novo Holdings (Catalent, Inc) Business Overview
11.5.3 Novo Holdings (Catalent, Inc) Induced Pluripotent Stem Cells Service Introduction
11.5.4 Novo Holdings (Catalent, Inc) Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.5.5 Novo Holdings (Catalent, Inc) Recent Development
11.6 Creative Bioarray
11.6.1 Creative Bioarray Company Details
11.6.2 Creative Bioarray Business Overview
11.6.3 Creative Bioarray Induced Pluripotent Stem Cells Service Introduction
11.6.4 Creative Bioarray Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.6.5 Creative Bioarray Recent Development
11.7 Creative Biolabs
11.7.1 Creative Biolabs Company Details
11.7.2 Creative Biolabs Business Overview
11.7.3 Creative Biolabs Induced Pluripotent Stem Cells Service Introduction
11.7.4 Creative Biolabs Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.7.5 Creative Biolabs Recent Development
11.8 iXCells Biotechnologies
11.8.1 iXCells Biotechnologies Company Details
11.8.2 iXCells Biotechnologies Business Overview
11.8.3 iXCells Biotechnologies Induced Pluripotent Stem Cells Service Introduction
11.8.4 iXCells Biotechnologies Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.8.5 iXCells Biotechnologies Recent Development
11.9 Creative Biogene
11.9.1 Creative Biogene Company Details
11.9.2 Creative Biogene Business Overview
11.9.3 Creative Biogene Induced Pluripotent Stem Cells Service Introduction
11.9.4 Creative Biogene Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.9.5 Creative Biogene Recent Development
11.10 Axol Bioscience Ltd.
11.10.1 Axol Bioscience Ltd. Company Details
11.10.2 Axol Bioscience Ltd. Business Overview
11.10.3 Axol Bioscience Ltd. Induced Pluripotent Stem Cells Service Introduction
11.10.4 Axol Bioscience Ltd. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.10.5 Axol Bioscience Ltd. Recent Development
11.11 Elixirgen Scientific, Inc.
11.11.1 Elixirgen Scientific, Inc. Company Details
11.11.2 Elixirgen Scientific, Inc. Business Overview
11.11.3 Elixirgen Scientific, Inc. Induced Pluripotent Stem Cells Service Introduction
11.11.4 Elixirgen Scientific, Inc. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.11.5 Elixirgen Scientific, Inc. Recent Development
11.12 Cyagen
11.12.1 Cyagen Company Details
11.12.2 Cyagen Business Overview
11.12.3 Cyagen Induced Pluripotent Stem Cells Service Introduction
11.12.4 Cyagen Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.12.5 Cyagen Recent Development
11.13 ALSTEM
11.13.1 ALSTEM Company Details
11.13.2 ALSTEM Business Overview
11.13.3 ALSTEM Induced Pluripotent Stem Cells Service Introduction
11.13.4 ALSTEM Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.13.5 ALSTEM Recent Development
11.14 uBriGene Biosciences International Co.
11.14.1 uBriGene Biosciences International Co. Company Details
11.14.2 uBriGene Biosciences International Co. Business Overview
11.14.3 uBriGene Biosciences International Co. Induced Pluripotent Stem Cells Service Introduction
11.14.4 uBriGene Biosciences International Co. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.14.5 uBriGene Biosciences International Co. Recent Development
11.15 NEXEL Co., Ltd.
11.15.1 NEXEL Co., Ltd. Company Details
11.15.2 NEXEL Co., Ltd. Business Overview
11.15.3 NEXEL Co., Ltd. Induced Pluripotent Stem Cells Service Introduction
11.15.4 NEXEL Co., Ltd. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024)
11.15.5 NEXEL Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Induced Pluripotent Stem Cells Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of iPSC Manufacturing Service
Table 3. Key Players of iPSC Reprogramming Service
Table 4. Key Players of iPSC Culture Service
Table 5. Key Players of iPSC Differentiation Service
Table 6. Key Players of iPSC Gene Editing Service
Table 7. Key Players of Other
Table 8. Global Induced Pluripotent Stem Cells Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Induced Pluripotent Stem Cells Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Induced Pluripotent Stem Cells Service Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Induced Pluripotent Stem Cells Service Market Share by Region (2019-2024)
Table 12. Global Induced Pluripotent Stem Cells Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Induced Pluripotent Stem Cells Service Market Share by Region (2025-2030)
Table 14. Induced Pluripotent Stem Cells Service Market Trends
Table 15. Induced Pluripotent Stem Cells Service Market Drivers
Table 16. Induced Pluripotent Stem Cells Service Market Challenges
Table 17. Induced Pluripotent Stem Cells Service Market Restraints
Table 18. Global Induced Pluripotent Stem Cells Service Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Induced Pluripotent Stem Cells Service Market Share by Players (2019-2024)
Table 20. Global Top Induced Pluripotent Stem Cells Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Induced Pluripotent Stem Cells Service as of 2023)
Table 21. Ranking of Global Top Induced Pluripotent Stem Cells Service Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Induced Pluripotent Stem Cells Service Revenue (CR5 and HHI) & (2019-2024)
Table 23. Global Key Players of Induced Pluripotent Stem Cells Service, Headquarters and Area Served
Table 24. Global Key Players of Induced Pluripotent Stem Cells Service, Product and Application
Table 25. Global Key Players of Induced Pluripotent Stem Cells Service, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Induced Pluripotent Stem Cells Service Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Induced Pluripotent Stem Cells Service Revenue Market Share by Type (2019-2024)
Table 29. Global Induced Pluripotent Stem Cells Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Induced Pluripotent Stem Cells Service Revenue Market Share by Type (2025-2030)
Table 31. Global Induced Pluripotent Stem Cells Service Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Induced Pluripotent Stem Cells Service Revenue Market Share by Application (2019-2024)
Table 33. Global Induced Pluripotent Stem Cells Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Induced Pluripotent Stem Cells Service Revenue Market Share by Application (2025-2030)
Table 35. North America Induced Pluripotent Stem Cells Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Induced Pluripotent Stem Cells Service Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Induced Pluripotent Stem Cells Service Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Induced Pluripotent Stem Cells Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Induced Pluripotent Stem Cells Service Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Induced Pluripotent Stem Cells Service Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Induced Pluripotent Stem Cells Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Induced Pluripotent Stem Cells Service Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Induced Pluripotent Stem Cells Service Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Induced Pluripotent Stem Cells Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Induced Pluripotent Stem Cells Service Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Induced Pluripotent Stem Cells Service Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Induced Pluripotent Stem Cells Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Induced Pluripotent Stem Cells Service Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Induced Pluripotent Stem Cells Service Market Size by Country (2025-2030) & (US$ Million)
Table 50. Lonza Company Details
Table 51. Lonza Business Overview
Table 52. Lonza Induced Pluripotent Stem Cells Service Product
Table 53. Lonza Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 54. Lonza Recent Development
Table 55. Thermo Fisher Scientific Inc. Company Details
Table 56. Thermo Fisher Scientific Inc. Business Overview
Table 57. Thermo Fisher Scientific Inc. Induced Pluripotent Stem Cells Service Product
Table 58. Thermo Fisher Scientific Inc. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 59. Thermo Fisher Scientific Inc. Recent Development
Table 60. FUJIFILM Cellular Dynamics, Inc. (FCDI) Company Details
Table 61. FUJIFILM Cellular Dynamics, Inc. (FCDI) Business Overview
Table 62. FUJIFILM Cellular Dynamics, Inc. (FCDI) Induced Pluripotent Stem Cells Service Product
Table 63. FUJIFILM Cellular Dynamics, Inc. (FCDI) Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 64. FUJIFILM Cellular Dynamics, Inc. (FCDI) Recent Development
Table 65. Charles River Laboratories Company Details
Table 66. Charles River Laboratories Business Overview
Table 67. Charles River Laboratories Induced Pluripotent Stem Cells Service Product
Table 68. Charles River Laboratories Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 69. Charles River Laboratories Recent Development
Table 70. Novo Holdings (Catalent, Inc) Company Details
Table 71. Novo Holdings (Catalent, Inc) Business Overview
Table 72. Novo Holdings (Catalent, Inc) Induced Pluripotent Stem Cells Service Product
Table 73. Novo Holdings (Catalent, Inc) Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 74. Novo Holdings (Catalent, Inc) Recent Development
Table 75. Creative Bioarray Company Details
Table 76. Creative Bioarray Business Overview
Table 77. Creative Bioarray Induced Pluripotent Stem Cells Service Product
Table 78. Creative Bioarray Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 79. Creative Bioarray Recent Development
Table 80. Creative Biolabs Company Details
Table 81. Creative Biolabs Business Overview
Table 82. Creative Biolabs Induced Pluripotent Stem Cells Service Product
Table 83. Creative Biolabs Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 84. Creative Biolabs Recent Development
Table 85. iXCells Biotechnologies Company Details
Table 86. iXCells Biotechnologies Business Overview
Table 87. iXCells Biotechnologies Induced Pluripotent Stem Cells Service Product
Table 88. iXCells Biotechnologies Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 89. iXCells Biotechnologies Recent Development
Table 90. Creative Biogene Company Details
Table 91. Creative Biogene Business Overview
Table 92. Creative Biogene Induced Pluripotent Stem Cells Service Product
Table 93. Creative Biogene Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 94. Creative Biogene Recent Development
Table 95. Axol Bioscience Ltd. Company Details
Table 96. Axol Bioscience Ltd. Business Overview
Table 97. Axol Bioscience Ltd. Induced Pluripotent Stem Cells Service Product
Table 98. Axol Bioscience Ltd. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 99. Axol Bioscience Ltd. Recent Development
Table 100. Elixirgen Scientific, Inc. Company Details
Table 101. Elixirgen Scientific, Inc. Business Overview
Table 102. Elixirgen Scientific, Inc. Induced Pluripotent Stem Cells Service Product
Table 103. Elixirgen Scientific, Inc. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 104. Elixirgen Scientific, Inc. Recent Development
Table 105. Cyagen Company Details
Table 106. Cyagen Business Overview
Table 107. Cyagen Induced Pluripotent Stem Cells Service Product
Table 108. Cyagen Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 109. Cyagen Recent Development
Table 110. ALSTEM Company Details
Table 111. ALSTEM Business Overview
Table 112. ALSTEM Induced Pluripotent Stem Cells Service Product
Table 113. ALSTEM Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 114. ALSTEM Recent Development
Table 115. uBriGene Biosciences International Co. Company Details
Table 116. uBriGene Biosciences International Co. Business Overview
Table 117. uBriGene Biosciences International Co. Induced Pluripotent Stem Cells Service Product
Table 118. uBriGene Biosciences International Co. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 119. uBriGene Biosciences International Co. Recent Development
Table 120. NEXEL Co., Ltd. Company Details
Table 121. NEXEL Co., Ltd. Business Overview
Table 122. NEXEL Co., Ltd. Induced Pluripotent Stem Cells Service Product
Table 123. NEXEL Co., Ltd. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 124. NEXEL Co., Ltd. Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Authors List of This Report
List of Figures
Figure 1. Induced Pluripotent Stem Cells Service Picture
Figure 2. Global Induced Pluripotent Stem Cells Service Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Induced Pluripotent Stem Cells Service Market Share by Type: 2023 VS 2030
Figure 4. iPSC Manufacturing Service Features
Figure 5. iPSC Reprogramming Service Features
Figure 6. iPSC Culture Service Features
Figure 7. iPSC Differentiation Service Features
Figure 8. iPSC Gene Editing Service Features
Figure 9. Other Features
Figure 10. Global Induced Pluripotent Stem Cells Service Market Size by Application (2024-2030) & (US$ Million)
Figure 11. Global Induced Pluripotent Stem Cells Service Market Share by Application: 2023 VS 2030
Figure 12. Pharmaceutical Company Case Studies
Figure 13. Laboratory Case Studies
Figure 14. Scientific Research Institution Case Studies
Figure 15. Induced Pluripotent Stem Cells Service Report Years Considered
Figure 16. Global Induced Pluripotent Stem Cells Service Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Induced Pluripotent Stem Cells Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Induced Pluripotent Stem Cells Service Market Share by Region: 2023 VS 2030
Figure 19. Global Induced Pluripotent Stem Cells Service Market Share by Players in 2023
Figure 20. Global Top Induced Pluripotent Stem Cells Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Induced Pluripotent Stem Cells Service as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Induced Pluripotent Stem Cells Service Revenue in 2023
Figure 22. North America Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Induced Pluripotent Stem Cells Service Market Share by Country (2019-2030)
Figure 24. United States Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Induced Pluripotent Stem Cells Service Market Share by Country (2019-2030)
Figure 28. Germany Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Induced Pluripotent Stem Cells Service Market Share by Region (2019-2030)
Figure 36. China Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Induced Pluripotent Stem Cells Service Market Share by Country (2019-2030)
Figure 44. Mexico Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Induced Pluripotent Stem Cells Service Market Share by Country (2019-2030)
Figure 48. Turkey Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. UAE Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Lonza Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 52. Thermo Fisher Scientific Inc. Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 53. FUJIFILM Cellular Dynamics, Inc. (FCDI) Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 54. Charles River Laboratories Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 55. Novo Holdings (Catalent, Inc) Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 56. Creative Bioarray Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 57. Creative Biolabs Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 58. iXCells Biotechnologies Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 59. Creative Biogene Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 60. Axol Bioscience Ltd. Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 61. Elixirgen Scientific, Inc. Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 62. Cyagen Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 63. ALSTEM Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 64. uBriGene Biosciences International Co. Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 65. NEXEL Co., Ltd. Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Induced Pluripotent Stem Cells Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of iPSC Manufacturing Service
Table 3. Key Players of iPSC Reprogramming Service
Table 4. Key Players of iPSC Culture Service
Table 5. Key Players of iPSC Differentiation Service
Table 6. Key Players of iPSC Gene Editing Service
Table 7. Key Players of Other
Table 8. Global Induced Pluripotent Stem Cells Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Induced Pluripotent Stem Cells Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Induced Pluripotent Stem Cells Service Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Induced Pluripotent Stem Cells Service Market Share by Region (2019-2024)
Table 12. Global Induced Pluripotent Stem Cells Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Induced Pluripotent Stem Cells Service Market Share by Region (2025-2030)
Table 14. Induced Pluripotent Stem Cells Service Market Trends
Table 15. Induced Pluripotent Stem Cells Service Market Drivers
Table 16. Induced Pluripotent Stem Cells Service Market Challenges
Table 17. Induced Pluripotent Stem Cells Service Market Restraints
Table 18. Global Induced Pluripotent Stem Cells Service Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Induced Pluripotent Stem Cells Service Market Share by Players (2019-2024)
Table 20. Global Top Induced Pluripotent Stem Cells Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Induced Pluripotent Stem Cells Service as of 2023)
Table 21. Ranking of Global Top Induced Pluripotent Stem Cells Service Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Induced Pluripotent Stem Cells Service Revenue (CR5 and HHI) & (2019-2024)
Table 23. Global Key Players of Induced Pluripotent Stem Cells Service, Headquarters and Area Served
Table 24. Global Key Players of Induced Pluripotent Stem Cells Service, Product and Application
Table 25. Global Key Players of Induced Pluripotent Stem Cells Service, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Induced Pluripotent Stem Cells Service Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Induced Pluripotent Stem Cells Service Revenue Market Share by Type (2019-2024)
Table 29. Global Induced Pluripotent Stem Cells Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Induced Pluripotent Stem Cells Service Revenue Market Share by Type (2025-2030)
Table 31. Global Induced Pluripotent Stem Cells Service Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Induced Pluripotent Stem Cells Service Revenue Market Share by Application (2019-2024)
Table 33. Global Induced Pluripotent Stem Cells Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Induced Pluripotent Stem Cells Service Revenue Market Share by Application (2025-2030)
Table 35. North America Induced Pluripotent Stem Cells Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Induced Pluripotent Stem Cells Service Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Induced Pluripotent Stem Cells Service Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Induced Pluripotent Stem Cells Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Induced Pluripotent Stem Cells Service Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Induced Pluripotent Stem Cells Service Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Induced Pluripotent Stem Cells Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Induced Pluripotent Stem Cells Service Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Induced Pluripotent Stem Cells Service Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Induced Pluripotent Stem Cells Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Induced Pluripotent Stem Cells Service Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Induced Pluripotent Stem Cells Service Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Induced Pluripotent Stem Cells Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Induced Pluripotent Stem Cells Service Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Induced Pluripotent Stem Cells Service Market Size by Country (2025-2030) & (US$ Million)
Table 50. Lonza Company Details
Table 51. Lonza Business Overview
Table 52. Lonza Induced Pluripotent Stem Cells Service Product
Table 53. Lonza Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 54. Lonza Recent Development
Table 55. Thermo Fisher Scientific Inc. Company Details
Table 56. Thermo Fisher Scientific Inc. Business Overview
Table 57. Thermo Fisher Scientific Inc. Induced Pluripotent Stem Cells Service Product
Table 58. Thermo Fisher Scientific Inc. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 59. Thermo Fisher Scientific Inc. Recent Development
Table 60. FUJIFILM Cellular Dynamics, Inc. (FCDI) Company Details
Table 61. FUJIFILM Cellular Dynamics, Inc. (FCDI) Business Overview
Table 62. FUJIFILM Cellular Dynamics, Inc. (FCDI) Induced Pluripotent Stem Cells Service Product
Table 63. FUJIFILM Cellular Dynamics, Inc. (FCDI) Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 64. FUJIFILM Cellular Dynamics, Inc. (FCDI) Recent Development
Table 65. Charles River Laboratories Company Details
Table 66. Charles River Laboratories Business Overview
Table 67. Charles River Laboratories Induced Pluripotent Stem Cells Service Product
Table 68. Charles River Laboratories Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 69. Charles River Laboratories Recent Development
Table 70. Novo Holdings (Catalent, Inc) Company Details
Table 71. Novo Holdings (Catalent, Inc) Business Overview
Table 72. Novo Holdings (Catalent, Inc) Induced Pluripotent Stem Cells Service Product
Table 73. Novo Holdings (Catalent, Inc) Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 74. Novo Holdings (Catalent, Inc) Recent Development
Table 75. Creative Bioarray Company Details
Table 76. Creative Bioarray Business Overview
Table 77. Creative Bioarray Induced Pluripotent Stem Cells Service Product
Table 78. Creative Bioarray Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 79. Creative Bioarray Recent Development
Table 80. Creative Biolabs Company Details
Table 81. Creative Biolabs Business Overview
Table 82. Creative Biolabs Induced Pluripotent Stem Cells Service Product
Table 83. Creative Biolabs Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 84. Creative Biolabs Recent Development
Table 85. iXCells Biotechnologies Company Details
Table 86. iXCells Biotechnologies Business Overview
Table 87. iXCells Biotechnologies Induced Pluripotent Stem Cells Service Product
Table 88. iXCells Biotechnologies Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 89. iXCells Biotechnologies Recent Development
Table 90. Creative Biogene Company Details
Table 91. Creative Biogene Business Overview
Table 92. Creative Biogene Induced Pluripotent Stem Cells Service Product
Table 93. Creative Biogene Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 94. Creative Biogene Recent Development
Table 95. Axol Bioscience Ltd. Company Details
Table 96. Axol Bioscience Ltd. Business Overview
Table 97. Axol Bioscience Ltd. Induced Pluripotent Stem Cells Service Product
Table 98. Axol Bioscience Ltd. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 99. Axol Bioscience Ltd. Recent Development
Table 100. Elixirgen Scientific, Inc. Company Details
Table 101. Elixirgen Scientific, Inc. Business Overview
Table 102. Elixirgen Scientific, Inc. Induced Pluripotent Stem Cells Service Product
Table 103. Elixirgen Scientific, Inc. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 104. Elixirgen Scientific, Inc. Recent Development
Table 105. Cyagen Company Details
Table 106. Cyagen Business Overview
Table 107. Cyagen Induced Pluripotent Stem Cells Service Product
Table 108. Cyagen Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 109. Cyagen Recent Development
Table 110. ALSTEM Company Details
Table 111. ALSTEM Business Overview
Table 112. ALSTEM Induced Pluripotent Stem Cells Service Product
Table 113. ALSTEM Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 114. ALSTEM Recent Development
Table 115. uBriGene Biosciences International Co. Company Details
Table 116. uBriGene Biosciences International Co. Business Overview
Table 117. uBriGene Biosciences International Co. Induced Pluripotent Stem Cells Service Product
Table 118. uBriGene Biosciences International Co. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 119. uBriGene Biosciences International Co. Recent Development
Table 120. NEXEL Co., Ltd. Company Details
Table 121. NEXEL Co., Ltd. Business Overview
Table 122. NEXEL Co., Ltd. Induced Pluripotent Stem Cells Service Product
Table 123. NEXEL Co., Ltd. Revenue in Induced Pluripotent Stem Cells Service Business (2019-2024) & (US$ Million)
Table 124. NEXEL Co., Ltd. Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Authors List of This Report
List of Figures
Figure 1. Induced Pluripotent Stem Cells Service Picture
Figure 2. Global Induced Pluripotent Stem Cells Service Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Induced Pluripotent Stem Cells Service Market Share by Type: 2023 VS 2030
Figure 4. iPSC Manufacturing Service Features
Figure 5. iPSC Reprogramming Service Features
Figure 6. iPSC Culture Service Features
Figure 7. iPSC Differentiation Service Features
Figure 8. iPSC Gene Editing Service Features
Figure 9. Other Features
Figure 10. Global Induced Pluripotent Stem Cells Service Market Size by Application (2024-2030) & (US$ Million)
Figure 11. Global Induced Pluripotent Stem Cells Service Market Share by Application: 2023 VS 2030
Figure 12. Pharmaceutical Company Case Studies
Figure 13. Laboratory Case Studies
Figure 14. Scientific Research Institution Case Studies
Figure 15. Induced Pluripotent Stem Cells Service Report Years Considered
Figure 16. Global Induced Pluripotent Stem Cells Service Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Induced Pluripotent Stem Cells Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Induced Pluripotent Stem Cells Service Market Share by Region: 2023 VS 2030
Figure 19. Global Induced Pluripotent Stem Cells Service Market Share by Players in 2023
Figure 20. Global Top Induced Pluripotent Stem Cells Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Induced Pluripotent Stem Cells Service as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Induced Pluripotent Stem Cells Service Revenue in 2023
Figure 22. North America Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Induced Pluripotent Stem Cells Service Market Share by Country (2019-2030)
Figure 24. United States Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Induced Pluripotent Stem Cells Service Market Share by Country (2019-2030)
Figure 28. Germany Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Induced Pluripotent Stem Cells Service Market Share by Region (2019-2030)
Figure 36. China Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Induced Pluripotent Stem Cells Service Market Share by Country (2019-2030)
Figure 44. Mexico Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Induced Pluripotent Stem Cells Service Market Share by Country (2019-2030)
Figure 48. Turkey Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. UAE Induced Pluripotent Stem Cells Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Lonza Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 52. Thermo Fisher Scientific Inc. Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 53. FUJIFILM Cellular Dynamics, Inc. (FCDI) Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 54. Charles River Laboratories Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 55. Novo Holdings (Catalent, Inc) Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 56. Creative Bioarray Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 57. Creative Biolabs Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 58. iXCells Biotechnologies Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 59. Creative Biogene Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 60. Axol Bioscience Ltd. Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 61. Elixirgen Scientific, Inc. Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 62. Cyagen Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 63. ALSTEM Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 64. uBriGene Biosciences International Co. Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 65. NEXEL Co., Ltd. Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Multi-Channel Temperature Controllers Market Research Report 2025
Mar 14, 25
Global Waterproof Action Cameras Market Research Report 2025
Mar 14, 25
Global Infrared IP Cameras Market Research Report 2025
Mar 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232